Syndicated research at AplusA delivers real-world data insights on a macro or micro level depending on your research needs. Our expertise in segmenting and sub-segmenting healthcare markets allows us to obtain deep, unique data sets and navigate the intricacies of specific markets.

 

Background Information: Asthma

Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation. It affects 1-18% of the population in different countries.

Recognizable clusters of demographic, clinical and/or pathophysiological characteristics are often called ‘asthma phenotypes’. Some of the most common are: Allergic asthma, Non-allergic asthma, Late-onset asthma, Asthma with fixed airflow limitation and Asthma with obesity.

 

Objectives of Syndicated Study

This syndicated study in both adult and pediatric asthma with a focus on biologic therapies. It captures real-world data in order to gain deep insights on:

  • Detailed patient profiles (symptoms, severity, etc.)
  • Patient profile by line, context and drugs
  • Asthma at diagnosis
  • Current asthma symptoms 
  • Current asthma assesment 
  • Current patient treatments for Asthma  (focus on controller and reliever therapies)
  • Biologic treatments modalities 
  • Asthma assessment before and after biologic treatment initiation 
  • Focus on previous treatment before current biologic therapy 
  • Reasons to use biologic treament or not 
  • Perception on patient's satisfaction and compliance
  • Optional social media listening

 

Overview of Research Topics 

Asthma Research Topics Visuel 3000

Planning

                                                                                                                                                         

 Wave 1 - Q4 2019                                                               Wave 2 - 2020                                      Frequency Flexible

 

                                                             

                                                                                                                   

 

Contact us